Catalyst Event
Biogen Inc (BIIB) · Earnings Release
From Akros U.S. Large Cap 500 Index (AUL500)
5/7/2026, 12:00:00 AM
Biogen's Q1 2026 earnings release is expected around this date, based on past reporting schedules. Earnings releases typically result in moderate price volatility.
Korean Translation
과거 실적 발표일에 근거하여, 바이오젠의 2026년 1분기 실적 발표가 이 날짜 전후로 예상됨. 실적 발표는 통상적으로 주가에 중간 정도의 변동성을 야기함.
Related Recent Events
Broadcom Inc (AVGO) · Earnings Release
Q2 2026 earnings release on June 4, 2026; a Medium impact is estimated as quarterly earnings are key drivers of stock volatility, scheduled.
6/4/2026, 12:00:00 AM
CME Group Inc (CME) · Other
CME Group will expand regulated cryptocurrency futures and options trading to 24/7 starting on 2026-05-29, pending regulatory review, scheduled.
5/29/2026, 12:00:00 AM
Dell Technologies Inc (DELL) · Earnings Release
Dell Technologies is scheduled to report its fiscal Q1 2027 earnings on May 28, 2026. Since earnings reports typically drive price movements exceeding 5%, significant volatility is scheduled.
5/28/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA PDUFA action date for the subcutaneous formulation of LEQEMBI for treatment initiation in early Alzheimer's disease is scheduled. This regulatory milestone is estimated to have a medium impact on stock price.
5/24/2026, 12:00:00 AM
ONEOK Inc (OKE) · Other
ONEOK 2026 annual meeting of shareholders on May 20, 2026, is estimated to have a price impact of at least 1% and is scheduled.
5/20/2026, 12:00:00 AM
Keysight Technologies Inc (KEYS) · Earnings Release
Keysight Technologies' fiscal second-quarter 2026 earnings report is scheduled for May 19, 2026; a price movement of 5% or more is expected.
5/19/2026, 12:00:00 AM